Apogee Therapeutics is a clinical-stage biotechnology company developing optimized, novel biologics for inflammatory and immunology (I&I) conditions including atopic dermatitis, asthma, eosinophilic esophagitis, and COPD. Its pipeline includes zumilokibart (APG777, anti-IL13), APG279 (zumilokibart + APG990, anti-OX40L), APG273 (zumilokibart + APG333, anti-TSLP), and APG808 (anti-IL-4R), all engineered with extended half-lives to enable infrequent subcutaneous dosing.
expected 2026-11-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001974640-26-000002 | EDGAR | 96K words |
| 2025-03-03 | 2024-12-31 | 0000950170-25-030385 | EDGAR | 101K words |
| 2024-03-05 | 2023-12-31 | 0001558370-24-002406 | EDGAR | 119K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-10 | 2026-06-30 | 0001193125-26-341289 | EDGAR | 66K words |
| 2025-11-10 | 2025-09-30 | 0001193125-25-273260 | EDGAR | 62K words |
| 2025-08-11 | 2025-06-30 | 0000950170-25-106234 | EDGAR | 60K words |
| 2025-05-12 | 2025-03-31 | 0000950170-25-068513 | EDGAR | 57K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124559 | EDGAR | 60K words |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095053 | EDGAR | 59K words |
| 2024-05-13 | 2024-03-31 | 0001558370-24-007861 | EDGAR | 55K words |
| 2023-11-13 | 2023-09-30 | 0001558370-23-018692 | EDGAR | 55K words |
| 2023-08-28 | 2023-06-30 | 0001558370-23-015278 | EDGAR | 51K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-03 | 0001140361-26-035537 | EDGAR | 7K words |
| 2026-08-11 | 0001140361-26-032231 | EDGAR | 1K words |
| 2026-08-10 | 0001193125-26-341239 | EDGAR | 4K words |
| 2026-03-25 | 0001104659-26-034579 | EDGAR | 29K words |
| 2026-03-23 | 0001104659-26-032950 | EDGAR | 7K words |
| 2026-03-02 | 0001974640-26-000001 | EDGAR | 2K words |
| 2026-01-06 | 0001104659-26-001063 | EDGAR | 4K words |
| 2025-11-10 | 0001193125-25-273250 | EDGAR | 3K words |
| 2025-10-10 | 0001104659-25-098487 | EDGAR | 29K words |
| 2025-08-11 | 0000950170-25-106228 | EDGAR | 3K words |
55 total filings indexed. 33 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001974640 |
| Ticker | APGE |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Website | https://www.apogeetherapeutics.com |
| Listed | 2023-07-14 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/APGE (~200 tokens, structured JSON with cryptographic provenance)